Tumor necrosis factor α antibody prevents brain damage of rats with acute necrotizing pancreatitis

World Journal of Gastroenterology

Volumn 10, Issue 19, 2004, Pages 2898-2900

  Yang, Yan Ling ^a   Li, Ji Peng ^a   Li, Kai Zong ^a   Dou, Ke Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MALONALDEHYDE; NEUROPROTECTIVE AGENT; SUPEROXIDE DISMUTASE; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE DUCT; BRAIN INJURY; BRAIN WATER; CONTROLLED STUDY; INJECTION; LEUKOCYTE ADHERENCE; MALE; MICROVASCULATURE; NEUROPROTECTION; NONHUMAN; PANCREAS DUCT; PATHOGENESIS; RANDOMIZATION; RAT STRAIN; STATISTICAL SIGNIFICANCE;

EID: 4644310261     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i19.2898     Document Type: Article

References (40)

1. Chan C, Fryer J, Herkes G, Prelog K, Harrington T. Fatal brain stem event complicating acute pancreatitis. J Clin Neurosci 2003; 10: 351-358
2. Ruggieri RM, Lupo I, Piccoli F. Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature. Neurol Sci 2002; 23: 203-205
3. Chen L, Zhang X. Pancreatic encephalopathy and Wernicke encephalopathy. Zhonghua Neike Zazhi 2002; 41: 94-97
4. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas 2003; 26: 122-129
5. Nam JH, Murthy S. Acute pancreatitis-the current status in management. Expert Opin Pharmacother 2003; 4: 235-241
6. Demols A, Deviere J. New frontiers in the pharmacological prevention of post-ERCP pancreatitis: the cytokines. JOP 2003; 4: 49-57
7. Algul H, Tando Y, Schneider G, Weidenbach H, Adler G, Schmid RM. Acute experimental pancreatitis and NF-kappaB/Rel activation. Pancreatology 2002; 2: 503-509
8. Noji T, Karasawa A, Kusaka H. Pharmacological study on the effects of the adenosine uptake inhibitor KF24345 on inflammatory diseases. Nippon Yakurigaku Zasshi 2003; 122: 121-134
9. Park BK, Chung JB, Lee JH, Suh JH, Park SW, Song SY, Kim H, Kim KH, Kang JK. Role of oxygen free radicals in patients with acute pancreatitis. World J Gastroenterol 2003; 9: 2266-2269
10. Dib M, Zhao X, Wang X, Andersson E, Drewsen G, Andersson R. Acute phase response in acute pancreatitis: a comparison with abdominal sepsis. Scand J Gastroenterol 2003; 38: 1072-1077
11. Strate T, Mann O, Kleinhans H, Schneider C, Knoefel WT, Yekebas E, Standl T, Bloechle C, Izbicki JR. Systemic intravenous infusion of bovine hemoglobin significantly reduces microcirculatory dysfunction in experimentally induced pancreatitis in the rat. Ann Surg 2003; 238: 765-771
12. Nakane A, Sasaki S. Effect of cytokines on the expression of Shiga toxin toxicity. Nippon Rinsho 2002; 60: 1089-1094
13. Klar E, Werner J. New pathophysiologic knowledge about acute pancreatitis. Chirurg 2000; 71: 253-264
14. Ogawa M. Acute pancreatitis and cytokines: "second attack" by septic complication leads to organ failure. Pancreas 1998; 16: 312-315
15. Miller AP, Chen YF, Xing D, Feng W, Oparil S. Hormone replacement therapy and inflammation: interactions in cardiovascular disease. Hypertension 2003; 42: 657-663
16. Herrera MT, Toledo C, Valladares F, Muros M, Diaz-Flores L, Flores C, Villar J. Positive end-expiratory pressure modulates local and systemic inflammatory responses in a sepsis-induced lung injury model. Intensive Care Med 2003; 29: 1345-1353
17. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 2002; 1: 343-351
18. Fang BW, Qiu Q, Wu XZ, Kong L, Qin MF, Zhou ZL, Cui NQ. Changes in pro-inflammatory cytokines and media and peptide hormones during multiple organ dysfunction syndrome following acute abdominal diseases. Zhongguo Weizhongbing Jijiu Yixue 2003; 15: 19-22
19. Austrums E, Pupelis G, Snippe K. Postoperative enteral stimulation by gut feeding improves outcomes in severe acute pancreatitis. Nutrition 2003; 19: 487-491
20. Isenmann R, Rau B, Zoellner U, Beger HG. Management of patients with extended pancreatic necrosis. Pancreatology 2001; 1: 63-68
21. Buter A, Imrie CW, Carter CR, Evans S, McKay CJ. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002; 89: 298-302
22. Zhang Q, Ni Q, Cai D, Zhang Y, Zhang N, Hou L. Mechanisms of multiple organ damages in acute necrotizing pancreatitis. Chin Med J 2001; 114: 738-742
23. Gloor B, Uhl W, Tcholakov O, Roggo A, Muller CA, Worni M, Buchler MW. Hydrocortisone treatment of early SIRS in acute experimental pancreatitis. Dig Dis Sci 2001; 46: 2154-2161
24. Desiateryk VI, Kryvyts'kyi IuM, Shapovaliuk VV. Inflammation response syndrome, sepsis and multi-organ insufficiency in patients operated for destructive pancreatitis. Klin Khir 2001; 4: 24-26
25. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410
26. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190: 117-125
27. Holtmann MH, Schutz M, Galle PR, Neurath MF. Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases. Z Gastroenterol 2002; 40: 587-600
28. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002; 10: 153-169
29. Bhatia M, Neoptolemos JP, Slavin J. Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs 2001; 2: 496-501
30. Reinheckel T, Deussing J, Roth W, Peters C. Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol Chem 2001; 382: 735-741
31. Yamauchi J, Shibuya K, Sunamura M, Arai K, Shimamura H, Motoi F, Takeda K, Matsuno S. Cytokine modulation in acute pancreatitis. J Hepatobiliary Pancreat Surg 2001; 8: 195-203
32. Brady M, Christmas S, Sutton R, Neoptolemos J, Slavin J. Cytokines and acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999; 13: 265-289
33. Markert R, Modzelewski B. Inflammatory mediators in the acute pancreatitis. Pol Merkuriusz Lek 1999; 6: 100-103
34. Zang GQ, Zhou XQ, Yu H, Xie Q, Zhao GM, Wang B, Guo Q, Xiang YQ, Liao D. Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models. World J Gastroenterol 2000; 6: 688-692
35. Silveira RC, Procianoy RS. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003; 143: 625-629
36. Gimenez F, Barraud de Lagerie S, Fernandez C, Pino P, Mazier D. Tumor necrosis factor alpha in the pathogenesis of cerebral malaria. Cell Mol Life Sci 2003; 60: 1623-1635
37. Kawada J, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Morishima T. Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 2003; 188: 690-698
38. Miura Y, Koyanagi Y, Mizusawa H. TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalophaty. J Med Dent Sci 2003; 50: 17-25
39. Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis 2003; 35: 59-61
40. Okamoto M, Ono M, Baba M. Suppression of cytokine production and neural cell death by the anti-inflammatory alkaloid cepharanthine: a potential agent against HIV-1 encephalopathy. Biochem Pharmacol 2001; 62: 747-753